AMLX - Amylyx Pharmaceuticals GAAP EPS of -$1.75 misses by $1.76 revenue of $88.64M misses by $9.71M
2024-05-09 07:16:29 ET
More on Amylyx Pharmaceuticals
- An ALS Drug Fails Again
- Amylyx Pharmaceuticals: Q4 Earnings Insight And PHOENIX Trial Implications
- Amylyx Pharmaceuticals, Inc. (AMLX) Q4 2023 Earnings Call Transcript
- Amylyx Pharmaceuticals Q1 2024 Earnings Preview
- Amylyx down 6% despite encouraging phase 2 data on rare disorder drug